POKR-p: Prediction of Outcomes Following Total Knee Replacement- Pilot

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04328701
Collaborator
(none)
40
1
2
56
0.7

Study Details

Study Description

Brief Summary

This study seeks to examine multiple risk factors as predictors of pain and function following total knee arthroplasty (TKA). Risk factors will be measured pre-surgically using psychophysical testing procedures, multimodal evaluation of sleep, standardized questionnaires. Additionally, this study will collect pilot data on a brief mindfulness-based cognitive-behavioral treatment that may help to improve long-term TKA outcomes.

The pilot study compared TKA patients that received brief mindfulness-based cognitive behavioral therapy (MBCBT) to the treatment-as-usual (TAU) group from the parent study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness-based Cognitive Behavioral Therapy
N/A

Detailed Description

The present study seeks to collect pilot data on a brief mindfulness-based cognitive-behavioral treatment to determine the feasibility of this intervention and its potential benefits. The study includes 6 total contacts, 1 visit before surgery and 3 after surgery, and 2 phone calls. The last visit will be about 6 months after surgery. The study includes evaluation of peoples' pain, physical functioning, medication use, and physiological responses to sensory stimuli such as heat and cold. The research takes place at the Brigham & Women's Pain Management Center, 850 Boylston St, Chestnut Hill.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
All participants will undergo quantitative sensory testing, physical functioning testing, and pain-related outcomes assessment. Participants in the intervention arm will undergo brief mindfulness-based cognitive behavioral sessions.All participants will undergo quantitative sensory testing, physical functioning testing, and pain-related outcomes assessment. Participants in the intervention arm will undergo brief mindfulness-based cognitive behavioral sessions.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Prediction of Outcomes Following Total Knee Replacement- Pilot
Actual Study Start Date :
Apr 1, 2018
Actual Primary Completion Date :
Apr 30, 2021
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness-based CBT

All participants will receive four individual mindfulness-based CBT sessions.

Behavioral: Mindfulness-based Cognitive Behavioral Therapy
Mindfulness-based CBT methods are based on pain self-management paradigms, and involve the identification and reduction of maladaptive pain-related cognitions (i.e., catastrophizing), the enhancement of self-efficacy for managing pain, and training in the use of adaptive pain-coping strategies such as relaxation, distraction, and self-talk.

No Intervention: Treatment as Usual

All participants will undergo surgery as usual, with no additional intervention.

Outcome Measures

Primary Outcome Measures

  1. Brief Pain Inventory (BPI) [baseline]

    Measure of pain severity and pain interference

  2. Brief Pain Inventory (BPI) [6-week]

    Measure of pain severity and pain interference

  3. Brief Pain Inventory (BPI) [3-months]

    Measure of pain severity and pain interference

  4. Brief Pain Inventory (BPI) [6-months]

    Measure of pain severity and pain interference

Secondary Outcome Measures

  1. Quantitative Sensory Testing (QST) [baseline]

    Measures of responses to standardized stimuli

  2. Quantitative Sensory Testing (QST) [3-months]

    Measures of responses to standardized stimuli

  3. Pain Catastrophizing Scale [baseline]

    Assess catastrophic thinking related to pain

  4. Pain Catastrophizing Scale [6-week]

    Assess catastrophic thinking related to pain

  5. Pain Catastrophizing Scale [3-months]

    Assess catastrophic thinking related to pain

  6. Pain Catastrophizing Scale [6-months]

    Assess catastrophic thinking related to pain

  7. PROMIS-SF [baseline]

    Measures anxiety and depression symptoms

  8. PROMIS-SF [6-week]

    Measures anxiety and depression symptoms

  9. PROMIS-SF [3-months]

    Measures anxiety and depression symptoms

  10. PROMIS-SF [6-months]

    Measures anxiety and depression symptoms

  11. The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) [baseline]

    24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.

  12. The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) [6-week]

    24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.

  13. The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) [3-months]

    24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.

  14. The Western Ontario McMaster Universities Osteoarthritis Scale (WOMAC) [6-months]

    24 items and is a well-validated, widely-used outcomes measure that yields three indices specific to osteoarthritis: 1) pain, 2) disability and 3) joint stiffness, which are sensitive to treatment, with internal consistency coefficients for all scales above 0.8.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 45 or older,

  2. Meet the American College of Rheumatology criteria for knee OA,

  3. Scheduled to undergo total knee arthroplasty,

  4. Facility with the English language that is adequate to complete study procedures

Exclusion Criteria:
  1. Cognitive impairment preventing completion of study assessment procedures.

  2. Myocardial infarction within the past 12 months.

  3. Presence of Severe Raynaud's or severe neuropathy,

  4. Active vasculitis or severe peripheral vascular disease,

  5. Current infection,

  6. Use of oral steroids,

  7. Recent history of substance abuse or dependence,

  8. Known anemia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Brigham and Women's Hospital Pain Management Center Chestnut Hill Massachusetts United States 02467

Sponsors and Collaborators

  • Brigham and Women's Hospital

Investigators

  • Principal Investigator: Robert Edwards, PhD, Brigham and Women's Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Robert Edwards, Clinical Psychologist, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT04328701
Other Study ID Numbers:
  • 2010P000978-p
First Posted:
Mar 31, 2020
Last Update Posted:
Jul 12, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Robert Edwards, Clinical Psychologist, Brigham and Women's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2022